Dow Down 0.08% Nasdaq Down 0.35%

AxoGen, Inc. (AXGN)

-NasdaqCM
4.95 Down 0.11(2.17%) Feb 9, 4:00PM EST
Prev Close:5.06
Open:4.96
Bid:N/A
Ask:5.10 x 300
1y Target Est:6.25
Beta:0.320195
Earnings Date:Mar 3 - Mar 7 (Est.)
Day's Range:4.80 - 4.96
52wk Range:2.95 - 5.95
Volume:34,407
Avg Vol (3m):85,347
Market Cap:147.93M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AXGNDown 2.17%147.93M
JNJDown 0.03%282.14B
IARTDown 1.08%2.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.22
Ex-Dividend Date:27-Jan-10

Analysts

Annual EPS Est (Dec-15) :-0.49
Quarterly EPS Est (Dec-15) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback